Cargando…
Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Science Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390086/ https://www.ncbi.nlm.nih.gov/pubmed/22783314 http://dx.doi.org/10.3724/SP.J.1263.2011.00260 |
| _version_ | 1782237397739634688 |
|---|---|
| author | Guo, Yong-Fang An, Yi |
| author_facet | Guo, Yong-Fang An, Yi |
| author_sort | Guo, Yong-Fang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3390086 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | Science Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-33900862012-07-10 Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker? Guo, Yong-Fang An, Yi J Geriatr Cardiol Letters to the Editor Science Press 2011-12 /pmc/articles/PMC3390086/ /pubmed/22783314 http://dx.doi.org/10.3724/SP.J.1263.2011.00260 Text en Institute of Geriatric Cardiology http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission. |
| spellingShingle | Letters to the Editor Guo, Yong-Fang An, Yi Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker? |
| title | Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker? |
| title_full | Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker? |
| title_fullStr | Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker? |
| title_full_unstemmed | Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker? |
| title_short | Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker? |
| title_sort | is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker? |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390086/ https://www.ncbi.nlm.nih.gov/pubmed/22783314 http://dx.doi.org/10.3724/SP.J.1263.2011.00260 |
| work_keys_str_mv | AT guoyongfang isheartratereductionmoreimportantthantargetdoseinchronicheartfailuretherapywithabetablocker AT anyi isheartratereductionmoreimportantthantargetdoseinchronicheartfailuretherapywithabetablocker |